When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Olaparib - Wikipedia

   en.wikipedia.org/wiki/Olaparib

   In January 2018, olaparib was approved in the United States for the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any ...

3. PARP inhibitor - Wikipedia

   en.wikipedia.org/wiki/PARP_inhibitor

   Pamiparib (BGB-290) For ovarian cancer, 1st patient enrolled May 2018. [30] It is a PARP1 and PARP2 inhibitor. [31] [32] Started Phase II: Olaparib (developed by AstraZeneca) for breast, ovarian and colorectal cancer. [33] [34] Olaparib TOPARP-A trial for use in advanced prostate cancer (published c. April 21, 2015). [35]

4. Padeliporfin - Wikipedia

   en.wikipedia.org/wiki/Padeliporfin

   Padeliporfin, sold under the brand name Tookad, is a medication used to treat men with prostate cancer. [1] [2] It is used in the form padeliporfin di-potassium.[2]The most common side effects include problems with urinating (pain, inability to pass urine, strong urge to pass urine, frequent urination, and incontinence), sexual problems (erectile dysfunction and ejaculation failure), blood in ...

5. Can Xtandi Become the Go-To Prostate Drug? - AOL

   www.aol.com/news/2013-09-20-can-xtandi-become...

   One out of every six men will be diagnosed with prostate cancer.-- American Cancer Society At some point, it's likely that all of us will know someone who has been diagnosed with prostate cancer.

6. J&J's Prostate Cancer Drug Zytiga Approved for Earlier ... - AOL

   www.aol.com/2013/01/11/jjs-prostate-cancer-drug...

   On Friday, Johnson & Johnson's Zytiga received an expanded approval from the European Commission. The drug was previously approved for patients with metastatic castration-resistant prostate cancer ...

7. AstraZeneca-Merck Lynparza Prostate Cancer Treatment ... - AOL

   www.aol.com/news/astrazeneca-merck-lynparza...

   AstraZeneca Plc’s (AZN) and Merck Co.’s (MRK) Lynparza drug has received a green light from the U.S. Food and Drug Administration (FDA) for the treatment of patients with advanced prostate ...